Dostinex Valvular Heart Disease

Dostinex (cabergoline) is used to treat hyperprolactinemic disorder, certain hormone problems (excess prolactin), and is used to reduce or prevent breast milk production, except after childbirth.

Dostinex may also be used for Parkinson's disease, prolactin-producing tumors and to adjust various hormone levels in certain diseases (ovarian diseases).

Dostinex, is a class of medications called "ergot-derived dopamine receptor agonists." Ergot is a fungus, and Ergot-derived dopamine receptor agonists were also present in the diet drug Fen-phen, which is also associated with heart valve disease.

Two studies have verified that Dostinex has the same dangerous side effects as fen-phen, valvular heart disease, that could result in a patient having to have valve replacement surgery, and in some cases, death has resulted. Thirty percent of people taking Dostinex are at increased risk of valvular heart disease.
 

Dostinex Articles

Parkinson's Patients At Risk With Off-Label Use of Dostinex
If you live in the United States and you are taking Dostinex for Parkinson's disease... You shouldn't be.

Dostinex Linked to Heart Valve Problems
Two recently published studies have linked Dostinex and Permax to serious heart valve problems, the same problems that were linked to fen-phen in the 1990s. Now, one of the drugs, Permax, has been pulled from the market and Dostinex has a new warning label.

Dostinex Valvular Heart Disease Legal Help

If you or a loved one has taken Dostinex and subsequently suffered valvular heart disease, please click the link below to send your complaint to a lawyer to evaluate your claim at no cost or obligation.
Last updated on Feb-4-22